...
首页> 外文期刊>Acta ophthalmologica >Efficacy of predetermined therapeutic measures against bleb‐related infection in the Collaborative Bleb‐related Infection Incidence and Treatment Study
【24h】

Efficacy of predetermined therapeutic measures against bleb‐related infection in the Collaborative Bleb‐related Infection Incidence and Treatment Study

机译:预定治疗措施对相关性感染率和治疗研究中的预定治疗措施对相关感染的疗效。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Purpose To report the efficacy of the predetermined treatment protocol of the Collaborative Bleb‐related Infection Incidence and Treatment Study ( CBIITS ) for bleb‐related infection ( BRI ) patients. Methods A prospective, observational cohort study was conducted at 34 clinical centres in Japan. Nineteen eyes from 19 patients that developed BRI were treated using the CBIITS protocol at 34 clinical centres. The visual acuity (VA) and intraocular pressure ( IOP ) were monitored for 6 and 12?months after treatment with the predetermined protocol. Results The log MAR was 0.623?±?0.748 (mean?±?standard deviation) before the infection developed. It was 1.054?±?1.156 and 0.950?±?1.168 at 6?months and 12?months post‐infection, respectively. However, in subgroup analyses, there was no significant decrease in post‐infection log MAR in stages I and II . In contrast, decimal VA was decreased ≥2 lines in all four cases in stage III . The IOP did not change after infection. It was 10.2?±?5.0?mmHg (range, 3–22?mmHg) before the infection developed, and 12.9?±?5.2?mmHg (5–24?mmHg) and 10.7?±?4.7?mmHg (3–18?mmHg) at 6?months and 12?months after infection, respectively. Conclusion Because of the small number of BRI patients, the superiority of the treatment was not definitively determined. However, VA was almost maintained in stages I and II , and the IOP did not change after infection. Although further study is necessary, the treatment protocol shown in the study might be a valuable treatment regime.
机译:摘要目的,报告具有博格布相关的感染(BRI)患者的协同β相关的感染发病率和治疗研究(CBIITS)的预定治疗方案的疗效。方法在日本34个临床中心进行了预期的观察队列研究。 19名患者的19名患者,在34名临床中心使用CBIITS方案进行治疗。在用预定方案处理后6和12个月监测视力(VA)和眼内压(IOP)。结果LOG MAR为0.623?±0.748(平均值?±(标准偏差)在发育中发育。它是1.054?±1.156和0.950?±1.168在6?月和12个月后感染后。然而,在亚组分析中,感染后没有显着减少在阶段I和II中。相比之下,在第三阶段的所有四种情况下,小数VA减少了≥2条线。感染后IOP没有改变。它在感染之前10.2?±5.0?5.0?mmhg(范围,3-22?mmhg),12.9?±5.2?mmhg(5-24?mmhg)和10.7?±4.7?mmhg(3-18 ?mmhg)在6?月和12个月,分别感染后数月。结论由于少数Bri患者,治疗的优越性并不明确地确定。然而,VA几乎保持在I和II的阶段,并且感染后IOP没有改变。尽管进一步研究是必要的,但研究中显示的治疗方案可能是有价值的治疗制度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号